Product Information

GABAPENTIN 100 MG CAPSULE is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0219 per EA under NDC 70010092610. Its NADAC has been published 198 times since Feb 1, 2023.

FDA first approved this application on Apr 6, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GABAPENTIN 100 MG CAPSULE

GABAPENTIN
$0.0219per EA

Strength

100 mg/1

NDC

70010092610

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA075360

FDA Approved

4/6/2005

TE Code

AB

On Market Since

9/1/2021

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 100 MG CAPSULE has been published 198 times since Feb 1, 2023, and over the history we have for it it has declined 16.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0219 per EA
All-time high$0.0276 (Dec 13, 2023)
All-time low$0.0186 (Nov 20, 2024)
52-week high$0.0219
52-week low$0.0208
Median price$0.0230
Average price$0.0232
Largest weekly change-19.1% (Nov 20, 2024)
Weeks tracked198
Tracking sinceFeb 1, 2023

Price History

1W

0.0%

1M

+0.4%

3M

+5.7%

6M

+4.1%

1Y

+3.8%

3Y

-11.2%

5Y

N/A

All

-16.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GABAPENTIN 100 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 100 MG CAPSULE, manufactured by Granules Pharmaceuticals Inc., is $0.0219 per EA (NDC 70010092610), effective Nov 11, 2026.

How has the price of GABAPENTIN 100 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 100 MG CAPSULE has declined 16.6%. It has been tracked across 198 weekly CMS publications since Feb 1, 2023.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 100 MG CAPSULE?

Since Feb 1, 2023, the NADAC for GABAPENTIN 100 MG CAPSULE has ranged from a low of $0.0186 (Nov 20, 2024) to a high of $0.0276 (Dec 13, 2023), with a median of $0.0230 per EA.

Are there cheaper alternatives to GABAPENTIN 100 MG CAPSULE?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 100 MG CAPSULE, is $0.0212 per EA — about 3% below GABAPENTIN 100 MG CAPSULE.

Who manufactures GABAPENTIN 100 MG CAPSULE?

GABAPENTIN 100 MG CAPSULE (NDC 70010092610) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.